Sign in

    Globus Medical Inc (GMED)

    Financials

    Updated May 8, 2025, 11:04 PM UTC
    Income Statement - MetricQ1 2014Q2 2014Q3 2014FY 2014Q1 2015Q2 2015Q3 2015FY 2015Q1 2016Q2 2016Q3 2016FY 2016Q1 2017Q2 2017Q3 2017FY 2017Q1 2018Q2 2018Q3 2018FY 2018Q1 2019Q2 2019Q3 2019FY 2019Q1 2020Q2 2020Q3 2020FY 2020Q1 2021Q2 2021Q3 2021FY 2021Q1 2022Q2 2022Q3 2022Q4 2022FY 2022Q1 2023Q2 2023Q3 2023Q4 2023FY 2023Q1 2024Q2 2024Q3 2024Q4 2024FY 2024Q1 2025
    Net sales (USD, thousands)616,534.001,568,476606,666629,691625,705657,293.002,519,355-
    Cost of sales (USD, thousands)265,486.00548,174241,487260,040----
    Cost of sales (exclusive of amortization of intangibles) (USD, thousands)----772,042-1,035,479-
    Gross profit (USD, thousands)351,048.001,020,302365,179369,651----
    Research and development (USD, thousands)52,252.00124,01057,26837,69835,38033,408.00163,754-
    Selling, general and administrative (USD, thousands)244,719.00643,410248,710238,119240,738253,481.00981,048-
    Provision for litigation, net (USD, thousands)-434(31)1,335(676)(314.00)314-
    Amortization of intangibles (USD, thousands)28,123.0051,03229,67629,70930,07629,912.00119,373-
    Acquisition-related costs (USD, thousands)15,581.0068,2742,41813,734(3,617)17,088.0029,623-
    Restructuring costs (USD, thousands)--19,141(566)5,1917.0023,773-
    Total operating expenses (USD, thousands)340,925.00887,160357,182320,029----
    Operating income/(loss) (USD, thousands)10,123.00133,1427,99749,62248,09860,274.00165,991-
    Interest income/(expense), net (USD, thousands)(2,581.00)20,130(1,894)(2,335)(775)815.00(4,189)-
    Foreign currency transaction gain/(loss) (USD, thousands)19,909.0014,259(15,371)(703)10,279(37,490.00)(43,285)-
    Other income/(expense) (USD, thousands)(2,456.00)(2,138)710997(570)1,068.002,205-
    Total other income/(expense), net (USD, thousands)14,872.0032,251(16,555)(2,041)8,934(35,607.00)(45,269)-
    Income/(loss) before income taxes (USD, thousands)24,995.00165,393(8,558)47,58157,03224,667.00120,722-
    Income tax provision/(benefit) (USD, thousands)9,961.0042,520(1,441)15,8215,196(1,838.00)17,738-
    Net income/(loss) (USD, thousands)15,034.00122,873(7,117)31,76051,83626,505.00102,984-
    Unrealized gain/(loss) on marketable securities (USD, thousands)6,252.0013,231379492912(238.00)1,545-
    Foreign currency translation gain/(loss) (USD, thousands)2,292.001,207(1,232)(1,298)3,976340.001,786-
    Total other comprehensive income/(loss), net of tax (USD, thousands)8,544.0014,438(853)(806)4,888102.003,331-
    Comprehensive income/(loss) (USD, thousands)23,578.00137,311(7,970)30,95456,72426,607.00106,315-
    Earnings per share: Basic (USD)0.021.09(0.05)0.230.380.200.76-
    Earnings per share: Diluted (USD)0.011.07(0.05)0.230.380.190.75-
    Weighted average shares outstanding: Basic (thousands)(201,102.00)113,087135,358135,195135,615(270,442.00)135,726-
    Weighted average shares outstanding: Diluted (thousands)(204,593.00)114,630135,358136,979138,062(272,536.00)137,863-
    Balance Sheet - MetricQ1 2014Q2 2014Q3 2014FY 2014Q1 2015Q2 2015Q3 2015FY 2015Q1 2016Q2 2016Q3 2016FY 2016Q1 2017Q2 2017Q3 2017FY 2017Q1 2018Q2 2018Q3 2018FY 2018Q1 2019Q2 2019Q3 2019FY 2019Q1 2020Q2 2020Q3 2020FY 2020Q1 2021Q2 2021Q3 2021FY 2021Q1 2022Q2 2022Q3 2022Q4 2022FY 2022Q1 2023Q2 2023Q3 2023Q4 2023FY 2023Q1 2024Q2 2024Q3 2024Q4 2024FY 2024Q1 2025
    Cash and cash equivalents (USD, thousands)467,292467,292354,062410,424622,766784,438784,438-
    Short-term marketable securities (USD, thousands)50,49750,49780,40882,50971,940105,619105,619-
    Accounts receivable, net (USD, thousands)503,235503,235534,333611,784588,047557,697557,697-
    Inventories (USD, thousands)848,135848,135816,196770,463717,703659,233659,233-
    Prepaid expenses and other current assets (USD, thousands)44,58044,58043,20946,21350,92449,64049,640-
    Income taxes receivable (USD, thousands)1,6351,6353662,4985,14920,63320,633-
    Total current assets (USD, thousands)1,915,3741,915,3741,828,5741,923,8912,056,5292,177,2602,177,260-
    Property and equipment, net (USD, thousands)586,932586,932578,887571,776567,822561,909561,909-
    Long-term marketable securities (USD, thousands)75,42875,42851,25627,79512,29766,13466,134-
    Intangible assets, net (USD, thousands)924,603924,603888,208866,565842,778795,117795,117-
    Goodwill (USD, thousands)1,434,5401,434,5401,451,1061,454,1171,431,6661,432,3871,432,387-
    Other assets (USD, thousands)78,59078,59078,21677,56976,64375,09675,096-
    Deferred income taxes (Assets) (USD, thousands)10,68510,68511,01818,19945,48594,20094,200-
    Total assets (USD, thousands)5,086,0835,086,0834,943,6124,993,7935,086,0445,251,7505,251,750-
    Accounts payable (USD, thousands)56,67156,67150,48767,16357,53775,11875,118-
    Accrued expenses (USD, thousands)240,460240,460210,011215,885255,260260,591260,591-
    Income taxes payable (USD, thousands)3,8453,84543,05811,4294,17410,72510,725-
    Business acquisition liabilities (Current) (USD, thousands)61,03561,03529,64938,22132,11033,73933,739-
    Deferred revenue (Current) (USD, thousands)18,36918,36917,07719,84520,80222,14022,140-
    Total current liabilities (USD, thousands)392,347392,347786,324794,146818,065855,913855,913-
    Business acquisition liabilities, net of current portion (USD, thousands)78,32378,32381,66183,11181,74889,49689,496-
    Deferred income taxes and other tax liabilities (Liabilities) (USD, thousands)84,42184,42139,95227,2647,47523,88923,889-
    Other liabilities (Non-current) (USD, thousands)24,59624,59623,50525,20522,98321,53121,531-
    Total liabilities (USD, thousands)1,088,1241,088,1241,021,2511,017,4281,016,6471,074,4171,074,417-
    Class A common stock (Value) (USD, thousands)114114113113113115115-
    Class B common stock (Value) (USD, thousands)22222222222222-
    Additional paid-in capital (USD, thousands)2,870,7492,870,7492,886,4362,913,6092,949,9173,031,2443,031,244-
    Accumulated other comprehensive income/(loss) (USD, thousands)(10,192)(10,192)(11,045)(11,851)(6,963)(6,861)(6,861)-
    Retained earnings (USD, thousands)1,137,2661,137,2661,046,8351,074,4721,126,3081,152,8131,152,813-
    Total equity (USD, thousands)3,997,9593,997,9593,922,3613,976,3654,069,3974,177,3334,177,333-
    Total liabilities and equity (USD, thousands)5,086,0835,086,0834,943,6124,993,7935,086,0445,251,7505,251,750-
    Cash Flow - MetricQ1 2014Q2 2014Q3 2014FY 2014Q1 2015Q2 2015Q3 2015FY 2015Q1 2016Q2 2016Q3 2016FY 2016Q1 2017Q2 2017Q3 2017FY 2017Q1 2018Q2 2018Q3 2018FY 2018Q1 2019Q2 2019Q3 2019FY 2019Q1 2020Q2 2020Q3 2020FY 2020Q1 2021Q2 2021Q3 2021FY 2021Q1 2022Q2 2022Q3 2022Q4 2022FY 2022Q1 2023Q2 2023Q3 2023Q4 2023FY 2023Q1 2024Q2 2024Q3 2024Q4 2024FY 2024Q1 2025
    Net income (USD, thousands)15,034.00122,873(7,117)31,760.00--102,984-
    Acquired in-process research and development (USD, thousands)--12,6130.00--12,613-
    Depreciation and amortization (USD, thousands)71,162.00144,73355,26163,588.00--254,024-
    Amortization of premiums on marketable securities (USD, thousands)24,063.0079324,482(24,496.00)--(635)-
    Provision for excess and obsolete inventory (USD, thousands)4,259.0010,9593,9146,584.00--23,359-
    Amortization of inventory fair value step-up (USD, thousands)-71,65653,67053,671.00--215,420-
    Amortization of 2025 Notes fair value step-up (USD, thousands)-8,1766,6586,657.00--26,630-
    Stock-based compensation expense (USD, thousands)12,445.0052,74217,26012,813.00--54,191-
    Change in fair value of business acquisition liabilities (USD, thousands)13,003.0017,434(165)12,904.00--26,521-
    Change in deferred income taxes (USD, thousands)(11,799.00)(57,789)(45,091)(20,184.00)--(125,902)-
    (Gain)/loss on disposal of assets, net (USD, thousands)75.001,54134430.00--5,552-
    Payment of business acquisition-related liabilities (Operating) (USD, thousands)(635.00)(3,005)(16,115)(850.00)--(18,763)-
    Net (gain)/loss from foreign currency adjustment (Operating) (USD, thousands)-(13,674)11,191(4,633.00)--25,212-
    (Increase) decrease in Accounts receivable (USD, thousands)(12,961.00)(49,914)(36,393)(87,813.00)--(78,062)-
    (Increase) decrease in Inventories (USD, thousands)(11,350.00)(70,328)(8,986)(13,869.00)--(29,860)-
    (Increase) decrease in Prepaid expenses and other assets (USD, thousands)2,428.001,1481,778(3,779.00)--1,059-
    Increase (decrease) in Accounts payable (USD, thousands)(6,271.00)(14,223)(5,753)17,314.00--17,663-
    Increase (decrease) in Accrued expenses and other liabilities (USD, thousands)(3,452.00)17,127(33,881)4,930.00--5,023-
    Increase (decrease) in Income taxes payable/receivable (USD, thousands)(13,794.00)(408)40,517(33,740.00)--(13,377)-
    Net cash provided by/(used in) operating activities (USD, thousands)104,674.00243,49952,38754,258.00--520,638-
    Purchases of marketable securities (USD, thousands)0.00(100,643)(8,017)(4,157.00)--(113,504)-
    Maturities of marketable securities (USD, thousands)25,760.00240,1908521,624.00--58,666-
    Sales of marketable securities (USD, thousands)317,736.00537,7232,5654,839.00--11,851-
    Purchases of property and equipment (USD, thousands)(22,881.00)(78,274)(28,568)(27,798.00)--(115,429)-
    Acquisition of businesses, net of cash acquired and purchases of intangible and other assets (USD, thousands)0.00(296,028)(12,649)(4,886.00)--(17,635)-
    Net cash provided by/(used in) investing activities (USD, thousands)320,615.00302,968(46,584)(10,378.00)--(176,051)-
    Payment of business acquisition-related liabilities (Financing) (USD, thousands)(2,131.00)(8,039)(30,475)(3,446.00)--(45,619)-
    Net proceeds from exercise of stock options (USD, thousands)1,040.0012,3973,41314,238.00--110,439-
    Payments related to tax withholdings for share-based compensation (USD, thousands)-(10,617)(5,343)(612.00)--(6,729)-
    Repurchase of common stock (USD, thousands)-(225,562)(83,316)(1,471.00)--(85,787)-
    Net cash provided by/(used in) financing activities (USD, thousands)(237,270.00)(231,821)(115,721)8,709.00--(27,696)-
    Effect of foreign exchange rates on cash (USD, thousands)(347.00)2,180(3,312)3,773.00--255-
    Net increase/(decrease) in cash and cash equivalents (USD, thousands)187,672.00316,826(113,230)56,362.00--317,146-
    Income taxes paid, net (USD, thousands)35,422.00100,5931,96769,619.00--158,508-
    Equity issued in conjunction with the NuVasive Merger (Non-cash) (USD, thousands)-2,153,860------
    Accrued purchases of property and equipment (Non-cash) (USD, thousands)1,129.007,1005,4264,082.00--9,281-
    Allowance for expected credit losses / doubtful accounts (USD, thousands)3,6583,6582,96811,48115,66716,98616,986-
    Cash and cash equivalents at beginning of period (USD, thousands)150,466150,466467,292467,292467,292467,292467,292-
    Cash and cash equivalents at end of period (USD, thousands)467,292467,292354,062410,424622,766784,438784,438-
    Revenue by Geography - in Millions of USDQ1 2014Q2 2014Q3 2014FY 2014Q1 2015Q2 2015Q3 2015FY 2015Q1 2016Q2 2016Q3 2016FY 2016Q1 2017Q2 2017Q3 2017FY 2017Q1 2018Q2 2018Q3 2018FY 2018Q1 2019Q2 2019Q3 2019FY 2019Q1 2020Q2 2020Q3 2020FY 2020Q1 2021Q2 2021Q3 2021FY 2021Q1 2022Q2 2022Q3 2022Q4 2022FY 2022Q1 2023Q2 2023Q3 2023Q4 2023FY 2023Q1 2024Q2 2024Q3 2024Q4 2024FY 2024Q1 2025
    United States490.841,279.765482.93499.459495.8521.912000.1483.9
    International125.69288.711123.74130.232129.9135.43519.3114.3
    - Europe and Middle East------116.9-
    - Latin America------26.8-
    - Asia Pacific------87.2-
    - Other International------288.4-
    Total Revenue616.531,568.476606.67629.691625.7657.342519.4598.1
    KPIs - Metric (Unit, Scale)Q1 2014Q2 2014Q3 2014FY 2014Q1 2015Q2 2015Q3 2015FY 2015Q1 2016Q2 2016Q3 2016FY 2016Q1 2017Q2 2017Q3 2017FY 2017Q1 2018Q2 2018Q3 2018FY 2018Q1 2019Q2 2019Q3 2019FY 2019Q1 2020Q2 2020Q3 2020FY 2020Q1 2021Q2 2021Q3 2021FY 2021Q1 2022Q2 2022Q3 2022Q4 2022FY 2022Q1 2023Q2 2023Q3 2023Q4 2023FY 2023Q1 2024Q2 2024Q3 2024Q4 2024FY 2024Q1 2025
    Number of countries in which products and services are sold (countries)-64616465-65-